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ABSTRACT 
Efforts to scale neuroimaging towards the direct visualization of mammalian brain-wide 
neuronal activity face major challenges. Although high resolution optical imaging of whole 
brain in small animals has been achieved ex vivo, the real-time and direct monitoring of 
large-scale neuronal activity remains difficult, owing to the performance gap between 
localized largely invasive optical microscopy of rapid, cellular-resolved neuronal activity and 
whole-brain macroscopy of slow hemodynamics and metabolism. Here, we demonstrate both 
ex vivo and entirely non-invasive in vivo functional optoacoustic neuroimaging of mice 
expressing the genetically encoded calcium indicators GCaMP6f. The approach offers rapid, 
high-resolution 3D snapshots of whole-brain neuronal activity maps with single optoacoustic 
excitations, and of stimulus-evoked slow hemodynamics and fast calcium activity in the 
presence of strong hemoglobin background absorption. By providing direct neuroimaging at 
depths and spatiotemporal resolutions superior to optical fluorescence imaging, functional 
optoacoustic neuroimaging bridges the gap between functional microscopy and whole-brain 
macroscopy. 
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TEXT 
 
Mammalian brain function arises through multi-scale interactions in a highly-interconnected, 
complex network of cortical and sub-cortical neurons1. Its understanding relies heavily upon 
experimental methods for monitoring neuronal activity at different spatial and temporal 
scales2. Whole-brain activity is typically imaged in both humans and small animals using 
methods that only indirectly reflect neuronal activity3-5, and thus recent efforts towards 
directly mapping neural network function have focused on fluorescence microscopy and the 
emerging toolbox of calcium and voltage indicators6. Techniques like two-photon microscopy 
can visualize the activity of thousands of neurons across multiple cortical layers7. However, 
optical brain microscopy approaches generally require invasive methods, namely, skull 
and/or scalp removal, and are further unable to resolve large-scale neuronal activity across 
entire rodent brains due to intense photon scattering. Despite recent developments in 
fluorescence microscopy8-10, achieving imaging rates exceeding 1mm3/s is still challenging2,10 
and real-time direct monitoring of large-scale neuronal activity in the mouse brain remains an 
unmet need. 
Hybrid opto-acoustic (OA) imaging techniques are ideally suited for real-time volumetric 
brain interrogations due to their intrinsic resilience to light scattering with a single laser pulse 
sufficient for inducing OA responses in the entire imaged tissue volume11. This provides an 
optimal trade-off between volumetric imaging rates and spatial resolution not achievable with 
other neuroimaging modalities11-13. Broadband ultrasound waves are generated by transient 
light absorption, enabling high-resolution imaging of optical contrast at centimeter-scale 
depths in tissue14,15, an order of magnitude gain over state-of-the-art optical microscopy. In 
addition, hemoglobin manifests excellent endogenous absorption contrast, and OA naturally 
attains label-free high fidelity images of vascular anatomy, blood oxygenation level and their 
respective dynamics, enabling the assessment and monitoring of multiple activity-related 
hemodynamic parameters in health and disease12,13,15-20.  
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Can the benefits of OA imaging be harnessed towards direct neuronal activity imaging? 
In recent work we demonstrated robust calcium-dependent OA contrast using a genetically 
encoded calcium indicator (GECI) in zebrafish larvae and excised brains11. While promising, 
the initial proof-of-concept demonstrations left important questions unanswered, ranging from 
the basic ability to image calcium responses in large and highly scattering and absorbing 
mammalian brains to whether the method is sensitive enough to observe natural sensory 
responses relative to the high background hemoglobin absorption signals at GCaMP 
excitation wavelengths. Here we devised customized functional OA neuro-tomography 
setups in order to demonstrate and characterize the capacity for real-time volumetric imaging 
of calcium transients across mouse brains expressing GECIs, further demonstrating that the 
OA method is sufficiently sensitive in detecting distributed sensory responses and setting the 
stage for future advances. 
 
RESULTS 
 
An isolated brain preparation 
To study the fundamental ability to optoacoustically image whole-brain calcium dynamics in 
the mammalian brain, we first developed and validated an isolated-brain preparation from 
GCaMP6f-expressing mice (see Methods for details of the model) and a custom imaging 
setup continuously perfused with artificial cerebrospinal fluid (ACSF). The blood-free model 
eliminates background hemodynamic signals, thus allowing for an unequivocal initial 
characterization of the calcium-related optoacoustic signal variations. It further enables 
deeper penetration of the 488nm light used for the GCaMP excitation. The isolated brain 
model exhibits high viability and functional neuronal activity for several hours (Suppl. Figs. 1-
3) and realistic optical light scattering and indicator responses. To evaluate neuronal viability 
of the in vitro model we intracortically injected isolated brains of CD-1 mice (n=3) with 10 kD 
dextran-conjugated Texas Red, an anterograde/retrograde tracer transported by live 
neurons21. The tracer stained structures up to 2 mm away from the injection site, with distant 
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staining observed exclusively in the viable dextran-conjugated dye group (Suppl. Figs. 1C-E). 
We further recorded electroencephalography (EEG) signals from the cortices of isolated 
brains perfused in oxygenated ACSF (n=3) vs. non-vital controls (n=3) and in vivo recordings 
(n=3) in order to evaluate the preparation’s electrophysiological function. We observed that 
injection of the epileptic drug pentylenetetrazol (PTZ) caused significant signal amplitude 
increases in EEG recordings, particularly in the higher 10-20 Hz frequency range in both 
isolated and in vivo brains, but not in the non-vital control brains (Suppl. Fig. 3), nor following 
injection of a 10-fold lower PTZ concentration22 (Fig. 3B). 
 
Volumetric optoacoustic and planar fluorescence of calcium activity in whole isolated 
mouse brains 
The developed hybrid imaging system allows for volumetric OA monitoring of resting and 
stimulus-evoked calcium dynamics concurrently with planar fluorescence imaging (Fig. 1). In 
the experimental set-up, seven optical fibers coupled to a pulsed laser source equally 
illuminated the brain from multiple directions while planar fluorescence and volumetric OA 
images were simultaneously captured using a sensitive camera and hemispherical-matrix 
ultrasound detection array (see schematic in Fig. 1A and Methods for details). The 512-
element spherical matrix transducer array with 5MHz central frequency and 140° angular 
tomographic coverage (Fig. 1B) was specifically designed to provide a field-of-view (FOV) of 
~2cm3 effectively covering the entire mouse brain with nearly isotropic three-dimensional 
(3D) resolution of ~150µm (see characterization data in Suppl. Fig. 4A-C). This corresponds 
to about one million individual voxels that can be visualized within the FOV at a volumetric 
imaging rate of 100 Hz (the maximal pulse repetition rate of the excitation laser). The system 
affords the acquisition of volumetric OA images covering the entire GCaMP6f-expressing 
brain along the transverse, sagittal and coronal planes with high resolution (Figs. 1C and 1E; 
n=4 brains imaged), providing a stark qualitative improvement over diffuse, surface-weighted 
2D wide-field fluorescence image lacking depth resolution (Fig. 1D). A range of gross 
anatomical features can be identified in the excised brains, such as the cortices, cerebellum, 
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medulla, thalamus, and hippocampus (Figs. 1E and 1F), demonstrating the system’s ability 
to volumetrically capture information from the entire brain.  
OA measurements of purified GCaMP6f proteins (Fig. 2A) rendered spectrally specific 
calcium-dependent absorption changes, suggesting that calcium concentration changes 
should be optoacoustically detectable in addition to their fluorescence signature. We 
therefore used the new system to acquire activity videos in isolated GCaMP6f mouse brains 
resulting from frontal-cortical injection of PTZ (n=4). This neuro-activating agent is assumed 
to interfere with GABAergic signaling and actuates fast seizure-like activity in the nervous 
system23. Large OA responses of up to 150% were readily observed following the injection 
(Fig. 2B), appearing to spatially propagate around the injection site (see the location of glass 
capillary in Fig. 1D) and into the uninjected hemisphere (Figs. 2E and 2F). This is consistent 
with previous observations of PTZ-induced brain-wide propagating calcium waves24, 
putatively indicating the preservation of inter-hemispheric communication in this in vitro 
model. Similar changes were also observed in the simultaneously acquired wide-field planar 
fluorescence images (Suppl. Figs. 5A, C), independently validating that the detected OA 
signals directly correspond to neuronal calcium dynamics. These responses were abolished 
during concurrent injections of the sodium channel blocker tetrodotoxin (TTX), a potent 
suppressor of neuronal activity25 (Fig. 2B). PTZ injection into control CD-1 mouse brains that 
did not express GCaMP6f resulted in no detectable OA or fluorescence signal increases 
(n=3, Fig. 2C and Suppl. Figs. 5B, D) and neither did control PBS injections into GCaMP6f-
labeled brains (n=3, Fig. 2D and Suppl. Fig. 5E). Notably, the observed relative fluorescence 
changes were an order of magnitude smaller (only up to 30% above baseline), most likely 
due to the diffuse nature and higher background noise of the wide-field fluorescence 
modality. 
 
Non-invasive 3D optoacoustic imaging of the whole mouse brain in vivo 
We next explored non-invasive (through intact skin and skull) volumetric in vivo OA 
recordings from the whole mouse brain using a customized experimental arrangement. Here, 
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the ultrasound array’s orientation was reversed and fluorescence versus OA imaging were 
performed sequentially due to geometrical constraints of the in vivo measurement setup (Fig. 
3A and Suppl. Fig. 6). GCaMP6f expression was clearly visible in the somatosensory cortex 
of the transgenic mice in vivo (Fig. 3B). The 3D OA images mainly exhibit vascular contrast 
related to the strong light absorption by hemoglobin (Fig. 3C). In addition, the limited light 
penetration at the peak excitation wavelength of GCaMP6f (488nm) is evident: at 488nm 
clear contrast is preserved up to ~1.5mm in depth (Fig. 3C), while images at the 650nm 
wavelength, where blood absorption diminishes significantly, clearly show visible absorption 
contrast across the entire brain down to ~7mm depth (Fig. 3D). The fluorescence signal 
photo-bleaches at a moderate rate of ~5% signal loss per 100 seconds of imaging (Fig. 3E, 
left) under experimental illumination conditions (~3 mJ/cm2 excitation light fluence reaching 
the scalp surface). This rate is consistent with the bleaching rate of the OA signal (Fig. 3E, 
right) and with earlier observations26. The fluorescence also recovered to pre-imaging levels 
within 24 hours due to protein recycling (data not shown). In order to further minimize protein 
bleaching, the laser beam could potentially be blocked for time intervals when no activity is 
expected. 
 
Brain-wide optoacoustic imaging of stimulus-locked calcium responses in vivo 
The in vivo imaging setup was then used to explore volumetric recordings of somatosensory-
evoked rapid calcium transients in GCaMP6f/6s-expressing mice. To detect stimulus-locked 
fluorescence and OA calcium-signals (Figs. 4A-B) while minimizing background 
hemodynamic responses,27 brief 50ms electrical stimulation pulses were repeatedly delivered 
to the hind-paw every 20s (Fig. 4C). The time lapse OA recordings imaging were carried out 
at 25Hz and fluorescence images were acquired at a lower 6.25Hz rate. Clearly resolvable 
stimulus-locked OA responses to each stimulus were readily observed in GCaMP6f mice 
(n=4 experiments in 3 mice), with typical average traces reaching a peak at ~360ms post 
stimulation, then rapidly decaying and reaching the baseline level at ~0.8s post stimulation 
(Figs. 4B-C), paralleling the temporal patterns of the observed fluorescence responses. 
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Interestingly, the normalized OA signal transients (ΔOA/OA) in the activated brain area were 
spatially correlated with and generally stronger than the separately measured normalized 
ΔF/F fluorescence responses (Fig. 4D), despite the very high blood background absorption 
levels inherently reflected in the OA signals. This difference is presumably attributable to 
intrinsic differences between these modalities, where the fluorescence signal traces 
effectively average calcium responses from a larger volume - such differences can be 
particularly prominent at deep locations, as also observed in the isolated brain experiments 
where OA and fluorescence responses were measured concurrently. Additionally, the in vivo 
OA recordings from deeper slices (Fig. 4B) exhibit distinct activation patterns not resolvable 
in the surface-weighted mesoscopic fluorescence images affected by the strong light 
scattering in the scalp, skull and the brain. Thus, OA imaging provides the additional depth 
information without sacrificing speed, allowing it to resolve neuronal activity in 3D with 
unparalleled spatio-temporal resolution (Suppl. Figs. 4D-F). Note that signal averaging 
across repeated responses results in a better rejection of noise and a clearer distinction of 
the activation peaks (Fig. 4E-F). No OA signal changes were detected in wild-type mice 
under the same brief 50ms electrical stimulation paradigm (Fig. 4G), confirming that this 
particular paradigm does not induce detectable hemodynamic changes. 
We further analyzed the functional OA signals of different voxels located in the 
somatosensory cortex and a major vessel (superior sagittal sinus, SSS). Clear bilateral 
activations can be seen in both planar fluorescence (Fig. 4E) and OA traces recorded from 
the somatosensory cortex areas outside major vessels at approximately 1mm depths (Fig. 
4F), and also in the stimulus-locked 4D spatio-temporal OA image sequences (Fig. 4B), 
which is consistent with previous reports of bilateral somatosensory cortical activations28,29. 
Bilateral activations were also consistently observed in control experiments using different 
strengths of the stimulation pulse, a different breathing gas and after using analgesia prior to 
stimulation experiments (Suppl. Fig. 7). To further corroborate that the detected signals 
correspond to calcium transients rather than to hemodynamic changes, we imaged GCaMP-
negative (wild-type) mice as controls using the same stimulation paradigm, observing no 
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signal spikes (Fig. 4G). On the other hand, when changing the stimulation paradigm to a 
longer stimulation pulse train, known to induce robust bilateral hemodynamic responses in 
blood-oxygen-level dependent (BOLD) functional magnetic resonance imaging (fMRI)30, OA 
signal changes could be clearly observed using multi-spectral measurements (Supp. Fig. 8). 
These findings show that both fast calcium-related activity and slow hemodynamic responses 
can be effectively measured optoacoustically. 
We also compared the OA responses of mice expressing fast GCaMP6f and slow 
GCaMP6s protein variants (Fig. 5A) and subjected both to the same hind-paw stimulation 
paradigm. Similar brain activation patterns and relative OA signal increases were observed 
for both mouse strains (cortical layers at ~1mm depth shown in Fig. 5B). The peak responses 
for GCaMP6f and GCaMP6s signals were produced at approximately the same time point 
following the stimulation pulse, while a slower decay was clearly observed in the GCaMP6s 
signals (Figs. 5C, left panel, and 5D, left panel). These observations are consistent with the 
time constants measured in fluorescence measurements (Figs. 5C, right panel, and 5D, right 
panel, images not shown) and with previously reported protein dynamics31. 
 
DISCUSSION 
 
Extensive efforts in optical neuroimaging are directed towards increasing the effective field of 
view and volumetric imaging rates of functional microscopy techniques, but the inherent 
advantages of OA approaches may allow the mapping of brain activity at depths and spatio-
temporal scales not achievable by other modalities. Our study examines fast OA signatures 
of GECIs in the densely vascularized and light-scattering mammalian brain, further showing 
that changes in their fluorescence are directly related to the OA responses, both in vitro and 
in vivo. We found that despite strong background hemoglobin absorption at the effective 
imaging wavelengths of GCaMP-type calcium indicators, the OA modality is sensitive enough 
to record sensory-evoked brain activity via GCaMP6f and GCaMP6s calcium-related signal 
changes that were in fact stronger than the corresponding fluorescence responses. This 
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represents an important milestone for direct OA neuroimaging, which is further empowered 
by its deep tissue real-time 3D imaging performance and the capacity to sense multiple 
cerebral oxygenation and hemodynamic parameters deep in the living rodent brain11,17, thus 
enabling direct investigations into mechanisms of neurovascular coupling32. 
Calcium transients and hemodynamic responses occur at significantly different time 
scales and hence can be distinguished using high-resolution temporal as well as auxiliary 
multi-spectral OA information (Supp. Fig. 8). Moreover, the capacity to potentially distinguish 
brain-wide time profiles associated with specific GECIs, further empowers OA with unique 
capabilities for assessing normal and dysregulated neural network interactions as well as for 
investigating the roles of other CNS cell types. Future work therefore includes 
implementation of the common neural network analysis strategies employed in mesoscopic 
fluorescence imaging and other functional neuroimaging techniques, such as resting-state 
networks, dynamic causal modelling and stimulus encoding-decoding analyses33. 
The imaging system was designed to capture neuronal dynamics in real time as true 3D 
information across effective fields of view of ~2cm3 covering an entire mouse brain at a 
spatial resolution of 150µm. In contrast, imaging a whole rodent brain with an advanced 
optical microscopy technique like OCT still requires slicing it to ~200µm thick layers34. To 
demonstrate this capability, we first tracked whole-brain calcium dynamics in a blood-free 
isolated-brain preparation. The isolated whole-brain has clear advantages for studying large-
scale recording capacity over conventional in vitro preparations like neuronal cultures2 or 
brain slices35, realistically capturing both long-range, whole-brain neural network interactions 
and overcoming the brain’s light-scattering properties. Multiple aspects of our method can be 
further improved. Imaging scalability can readily be achieved using high-frequency matrix 
array probes for better spatial resolution, but at the expense of a smaller FOV11, and of 
increased skull-mediated distortions of the high-frequency ultrasound wave components36. In 
the current implementation, the mouse’s head is fixed during the acquisition to prevent 
motion. Ultrasound arrays with a relatively low number of elements attached to a rodent’s 
head in order to acquire ultrasound echoes and OA signals13,37 have recently been designed. 
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Thus, our proposed technique can potentially be adapted to study freely behaving animals. 
GCaMP6f, the fastest GCaMP6-family indicator31, was chosen here since the system’s rapid 
acquisition time (10ms) dictated that the indicator dynamics limit the effective temporal 
resolution. Slower indicator variants can be imaged instead for improved signal 
characteristics, while other major advances can arise from the development and use of new 
activity indicators by leveraging the wide tunability of the lasers used in our technology. Other 
options include the newer generations of GCaMP-type38,39 and red-shifted probes like 
RGECO40, although their peak extinction still falls within the range of strong absorption by 
hemoglobin. The long-anticipated development of far-red and near-infrared calcium 
indicators41 with absorption peak above 650nm may eventually enable OA imaging in the 
presence of a significantly lower blood absorption background, reaching deeper brain regions 
in vivo thus potentially enabling non-invasive monitoring of activity across the entire living 
rodent brain (Fig. 3D).  
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METHODS 
 
Isolated Brain Preparation 
Brains of female CD-1 as well as GCaMP6f-expressing mice aged 8 to 12 weeks were used 
in these experiments. This animal experiment was carried out in full compliance with the 
institutional guidelines of the Institute for Biological and Medical Imaging along with approval 
from the Government District of Upper Bavaria. Mice were injected intraperitoneally with a 
lethal dose of Ketamine/Xylazine. Subsequently, intracardiac perfusion with ice-cold PBS 
was performed in order to remove blood from the brain. For this, once the animal was 
completely anaesthetized, as determined by the absence of a toe-pinch reflex, surgery 
began with an incision from the mid abdomen to the sternum. The ventral part of the rib cage 
was removed to allow access to the heart. The intracardiac perfusion was then carried out 
after inserting a 25G butterfly needle into the left ventricle of the heart followed by an incision 
into the right atrium. The heart was perfused until both liver and lungs turned white, at which 
stage decapitation was performed. Next, all tissue and skin surrounding the skull was 
removed and the skull was rinsed with ice-cold PBS to remove any remaining debris. A cut 
was then made between the skull and the first cervical vertebra exposing the brain stem. 
Using bone scissors, a second cut was made on both sides of the skull, which extended from 
the foramen magnum to the external auditory meatus, and then from the molar process up to 
the lachrymal dorsal aspect of the skull (Suppl. Fig. 1B). Using forceps, the upper skull plate 
together with the brain was separated from the lower skull and placed into a Petri dish filled 
with ice-cold, oxygenated artificial cerebrospinal fluid (ACSF). The brain was then carefully 
separated from the skull using forceps and placed in a second petri dish filled with fresh 
ACSF. Any remaining hair, debris and blood vessels were removed using fine forceps and a 
pipette.  
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Dextran tracing 
Axonal tracer transport requires intact, functioning neurons and dextran-amines coupled to 
fluorescent molecules are known for being transported in both the anterograde and 
retrograde direction21. 10 kDa dextran coupled to Texas-red (ThermoFisher Scientific Inc., 
Waltham, MA, USA) was injected directly into the cortex of the excised brains preparations in 
order to validate the functionality of axonal transport. The experimental setup is illustrated in 
Suppl. Fig. 2A. Freshly excised brains were placed in a custom-made chamber filled with 
ACSF and with a constant supply of carbogen (95% O2, 5% CO2) to keep the solution 
oxygenized and the pH stable at physiological conditions. For intra-brain injection at a depth 
of ~1 mm inside the cortex, a wireless robotic injection system (Neurostar, Tuebingen, 
Germany) using a 15 to 25 µm diameter glass microcapillary was utilized. As controls, either 
PBS or Texas red (without Dextran) were injected under the same conditions. Afterwards, 
the brains were fixated in paraformaldehyde either immediately after injection, or after being 
kept in oxygenized ACSF at 4°C in the dark for 1 h. Fixated brains were then sliced into 
50 µm-thick sections to evaluate axonal transport. For this, the brains were first dehydrated 
in a solution of 30% sucrose at 4°C for 48 h to remove water and prevent ice-crystal 
formation during cryo-slicing. Subsequently, the brains were embedded in optimal cutting 
temperature compound (Tissue-Tek® O.C.T. compound, VWR, Darmstadt, Germany) and 
sliced into 50 µm-thick sections along the coronal plane using a CM 1950 cryo-slicer (Leica 
Biosystems, Wetzlar, Germany). These cryo-sections were mounted onto microscope slides 
and air-dried for 20 min in the dark. A coverslip was placed on top of the slices and sealed 
with Vectashield containing DAPI (Vector Laboratories Inc, Burlingame, CA, USA). DAPI 
stains the DNA and RNA of cells, hence outlining cellular anatomy. Compound brain slice 
images were captured using an Imager.M2 microscope fitted with shift-free DAPI and Texas 
red filter sets (Carl Zeiss AG, Oberkochen, Germany). Image acquisition was done using the 
Zen 2 microscope software (Carl Zeiss AG, Oberkochen, Germany). 
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Electroencephalography recording 
The experimental setup for electroencephalography (EEG) recordings from the isolated 
brains is depicted in Suppl. Fig. 2B. The excised brains were placed in the custom-made 
chamber filled with oxygenized ACSF at room temperature (RT). To induce neuronal activity, 
5 µL of pentylenetetrazol (PTZ; 100 mg/ml in PBS) was directly injected into the cortex using 
a glass capillary and a robotic injection system (Neurostar, Tuebingen, Germany). EEG-
signals were recorded via two custom-made needle electrodes, connected to a DP-311 
differential amplifier (Warner Instruments, LLC, Hamden, CT, USA). The amplified signals 
were digitized by means of a PowerLab26T data acquisition module (AD Instruments, 
Sydney, Australia) controlled through a host PC running the Labchart 8 software (AD 
Instruments, Sydney, Australia). The amplifier gain value was set to 100 due to relatively low 
signal strengths for EEG-recordings in isolated brains. For comparison, in vivo EEG of a CD-
1 mouse was also recorded, as described previously12. This animal experiment was 
performed in full compliance with the institutional guidelines of the Institute for Biological and 
Medical Imaging and with approval from the Government District of Upper Bavaria. In order 
to induce widespread brain activity, the epileptic drug PTZ was injected intraperitoneally24. 
For in vivo EEG-recording, the amplifier was set to a high pass of 10 Hz, a low pass of 
100 Hz and a gain of 100. After baseline recording, 100 µL of PTZ (25 mg/ml in PBS) was 
injected intraperitoneally and EEG-signals were recorded for at least 25 minutes. At the end 
of the experiment, the mouse was euthanized while still under anesthesia. The recorded 
EEG signals were processed using MatLab (MathWorks, Natick, United States) to identify 
periods of neuronal activity. For this, the spectrograms of the EEG signals were calculated as 
the short-time Fourier transform with a window of 20 seconds, which is sufficient to detect 
higher frequency components in the range of 10-20 Hz corresponding to seizure-like activity 
caused by PTZ. 
 
In vivo animal handling  
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Eight- to twelve-week-old female C57BL/6J-Tg(Thy1-GCaMP6f)GP5.5Dkim/J and C57BL/6J-
Tg(Thy1-GCaMP6s)GP4.12Dkim/J (The Jackson Laboratory, Bar Harbor, ME, USA; stock 
numbers 024276 and 025776, respectively) along with six- to twelve-week-old athymic 
female nude mice (Envigo, New Jersey, USA; stock number Foxn1nu 069) were used for the 
in vivo experimentation in full compliance with the institutional guidelines of the Institute for 
Biological and Medical Imaging and with approval from the Government District of Upper 
Bavaria. Mice were anesthetized with isoflurane (2.5% v/v for induction) in 100% O2, and 
when necessary, any fur on the head of the mouse was removed using consumer hair-
removal cream prior to experiments. To avoid motion artifacts during imaging, the head of 
the mouse was fixed into a custom designed stereotactic mouse head holder, which was 
coupled to an anesthetic breathing mask (Narishige International Limited, London, United 
Kingdom). During experiments the animals were maintained under isoflurane anesthesia with 
1.0% to 1.5% v/v in 100% O2 with a flow rate of ~0.7 L/min and the physiological parameters 
(blood oxygenation, heart rate, and body temperature) of the animals were continuously 
monitored using a PhysioSuite™ physiological monitor (Kent Scientific, Torrington, 
Connecticut). The core body temperature was tracked and maintained at ~36°C using a 
homeothermic temperature controller coupled to a heating pad, both being controlled by the 
PhysioSuite™. For analgesia, a single drop of 125mg/mL metamizole was given orally prior 
to experiments (Novalgin®, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, 
Germany). 
 
Hindpaw Electrical Stimulation 
For GCaMP imaging hindpaw stimulation was applied by inserting thin stainless steel needle 
electrodes under the skin of the paw in isoflurane-anesthetized mice. Electrical stimulation 
with 50 ms-duration pulses at a constant current of 1 mA was employed using a constant 
current stimulus isolator (Model A365R, World Precision Instruments, Sarasota, FL, USA). 
The block stimulation paradigm consisted of repeating the pulses every 20 seconds (Fig. 
4C). For the induction and imaging of hemodynamic responses, the following stimulation 
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paradigm was carried out instead: one hundred 500μs duration pulses were applied at 0.5mA 
every 200ms for 20s. Stimulation began 30s into the imaging cycle to allow baseline activity 
approximation. The optoacoustic (OA) or fluorescence data acquisitions were synchronized 
with the start of the first cycle.   
 
Imaging set-up 
The OA tomography system used for real-time volumetric acquisition of data consists of a 
custom-made spherical transducer array (Imasonic SaS, Voray, France). The spherical 
surface has a 40 mm radius and consists of 512 piezocomposite elements covering an angle 
of 140° (1.32€ solid angle). The elements have a diameter of 2.5 mm, 5 MHz central 
frequency and approximately 100% -6 dB detection bandwidth, providing a nearly isotropic 
resolution of 150 µm around the center of the spherical geometry and an effective field of 
view of approximately 2 cm3. The imaging resolution and field of view were characterized 
with an agar phantom containing sparsely distributed ~50 μm diameter polyethylene 
absorbing spheres (Cospheric LLC, Santa Barbara, USA). The image of the phantom (top 
maximum intensity projection) rendered with the system is displayed in Suppl. Fig. 4. The 
resolution at the center of the spherical array was estimated as the mean square difference 
between the measured sphere’s full width at half maximum and its actual diameter. The field 
of view was estimated as the size of the region containing particles reconstructed with an 
amplitude higher than 50% of the maximum signal in the images. 
 
Isolated brain imaging 
For imaging of the isolated brains, the array was held pointing upwards by a custom-made 
3D-printed holder attached to a X-Y positioning platform. The holder further allowed for 
superfusion of ACSF around the excised brain via an inlet and an outlet, thus establishing a 
physiological environment supporting brain vitality (Fig. 1A). Excised brains were placed at 
approximately the center of the spherical geometry lying upon a ~10 µm thin transparent 
polyethylene foil. Illumination was provided via a self-made fiber bundle consisting of seven 
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fibers, each with a core diameter of 600 µm. One of the fibers was inserted into a cylindrical 
cavity of the spherical array to illuminate the bottom part of the brain while the other 6 fibers 
were inserted into the holder and equally spaced at 120° in azimuthal direction and with polar 
angles of 5.7° and 37° (Fig. 1A). The illumination source was an optical parametric oscillator 
(OPO)-based laser (Innolas GmbH, Krailling, Germany) providing short (<10 ns) pulses at 
repetition frequency of 100 Hz whose optical wavelength is freely tunable between 420 to 
680 nm. The 512 OA signals detected by the matrix array elements were simultaneously 
digitized with a custom-made data acquisition system (Falkenstein Microsysteme GmbH, 
Taufkirchen, Germany) triggered with the Q-switch output of the laser. The digitized signals 
were transferred to a computer via 1 Gbit/s Ethernet connection. To record fluorescence 
signals, a high speed scientific complementary metal-oxide semiconductor (sCMOS) camera 
(Andor Technology Ltd, Belfast, UK) was positioned on top of the holder pointing downwards 
and synchronized with the pulsed laser source. The camera was equipped with a manually 
focusing 105 mm Nikon F mount objective (Nikon, Chiyoda, Tokio, Japan) and a one-inch 
bandpass filter (525 nm center wavelength and 39 nm bandwidth; MF525-39, Thorlabs Inc, 
Newton, USA). The acquisition time of the camera was set to 160 ms, corresponding to the 
integration of 4 laser pulses.  
 
In vivo imaging experiments 
For the in vivo imaging experiments, the OA tomography system was used in a reversed 
orientation (Suppl. Fig. 6B) The wide-field fluorescence recordings were not performed 
concurrently due to the lack of access to the imaged area in the in vivo setting. Also, the 
laser light beam was guided differently from the isolated brain setup, i.e. a single custom-
made silica fused-end fiber bundle (CeramOptics GmbH, Bonn, Germany) was used to 
broadly illuminate the imaged area from a single direction. At the peak absorption 
wavelength of calcium-saturated GCaMP6f/6s of 488 nm, the light fluence at the sample was 
measured to be ~3 mJ/cm2, i.e. below safe exposure limits for pulsed laser radiation42. The 
same fiber bundle was used to illuminate the shaved mouse head. However, fluorescence 
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imaging was performed separately with the mouse head illuminated laterally to avoid blinding 
the camera, as indicated in Suppl. Fig. 6A. 
Imaging of GCaMP-responses were done at 25 Hz laser repetition frequency and a single 
excitation wavelength of 488 nm. Optoacoustic imaging of hemodynamic imaging was 
carried out instead at 20 Hz with five wavelengths (530,540,560,575 and 585 nm). This 
resulted in an imaging rate of 4 Hz per wavelength and allowed for the unmixing of two blood 
components: oxygenated hemoglobin (HbO) and reduced hemoglobin (HbR). Total 
hemoglobin (HbT) was estimated as the sum of these two components. A 100µm black 
microsphere (BKPMS-1.2 90-106um, Cospheric, USA) was placed in the field of view, right 
above the skin of the mouse and used to normalize the optoacoustic images with the per-
pulse laser energy variations (assumed to be proportional to the optoacoustic signal of the 
sphere).  
 
Isolated protein measurements 
The optoacoustic spectrum of the isolated proteins was measured with the same system by 
injecting the proteins (~50µM concentration) in a polyethylene tubing with 0.57mm inner 
diameter. The laser was tuned between 420 and 580 nm with 5 nm step on a per pulse basis 
and averaging of 50 multi-spectral datasets was performed. For the measurements, the 
proteins were first diluted in a buffer containing 30mM 4-Morpholinepropanesulfonic acid 
(MOPS), 100mM KCl (pH 7.2) and 1mM MgCl2 was subsequently added to mimic 
physiological conditions. Calcium-free and calcium-saturated protein-solutions were rendered 
by adding 10mM EGTA orn100µM CaCl2, respectively, to the solution. 
 
Imaging data analysis and processing 
Volumetric (3D) OA images were reconstructed from the acquired signals with a graphics 
processing unit (GPU)-based implementation of a back-projection formula43. Prior to 
reconstruction, the signals were deconvolved with the impulse response of the transducer 
array elements and band-pass filtered with cut-off frequencies of 0.1 and 6 MHz. 
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Reconstruction was performed on a grid of 150x150x100 voxels3 (FOV of 15x15x10 mm3) to 
better match the 150µm spatial resolution of the system. The reconstructed images were 
normalized with the estimated light fluence distribution Φ(𝑟, 𝑡) to compensate for light 
attenuation within the sample according to the light diffusion equation with no transient 
effects and no internal light sources44 
𝜇𝑎Φ(𝑟, 𝑡) − 𝐷∇
2Φ(𝑟, 𝑡) = 0,                                         (1) 
where 𝐷 = 1/3(𝜇𝑎 + 𝜇′𝑠), 𝜇𝑎 and 𝜇′𝑠 are the optical absorption and reduced scattering 
coefficient, respectively. The solution of (1) for a uniformly illuminated spherical target is 
given by a modified spherical Bessel function45 via 
Φ(𝑟, 𝑡) =
Φ0
sinh⁡(𝑘𝑅)
𝑘𝑅
sinh⁡(𝑘𝑟)
𝑘𝑟
                            (2) 
where 𝑅 is the radius of the sphere, 𝑟 is the distance from its center, Φ0 is the fluence at the 
surface and 𝑘 = √𝜇𝑎/𝐷. A predictive Kalman filter was further applied on a per-slice basis to 
the time domain of the sequence of reconstructed OA images for noise removal46.  
The effect of bleaching in OA signal decay during the stimulation-evoked activity 
experiment was estimated as follows. A Kalman filter with gain 0.75 was applied to the 
individual time profiles of the OA signal intensity for a location in the brain having a clear 
activation peak. The average time profile for all cycles was taken as reference. All profiles 
were windowed to the initial 4 s following the hind paw stimuli. The OA signal intensity 
associated to GCaMP as a function of time was estimated by cross-correlation of the 
individual profiles and the reference profile. A 10-point moving average filter was applied to 
the calculated cross-correlation values, which were subsequently normalized to the 
maximum value. An exponential decay function was eventually fitted to these values. 
The onset time for the appearance of activity after PTZ injection in the isolated brain 
experiments was estimated as follows. First, the standard deviation of the background OA 
signal intensity for each voxel of the reconstructed image was calculated for a window of 300 
consecutive frames (40ms per frame) where no PTZ-related activity occurred. The onset time 
was estimated by considering the time point at which the OA signal exceeds the standard 
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deviation of the background signal by a factor of 3. It was assumed that no activation was 
produced at voxels for which the OA signal intensity did not reach this value.  
For analysis of the hemodynamics-related optoacoustic signal changes, the multi-spectral 
optoacoustic data was first reconstructed as outlined above on a per-wavelength basis. A 
spatial moving average of 3x3 voxels and a temporal forward moving average of 10 frames 
(2.5s) was applied to the time-lapse volumetric data sets. The images were then unmixed for 
HbO, HbR and HbT on a per-voxel basis according to their absorption spectrum at the five 
excitation wavelengths by assuming a linear unmixing model12,17. Delta calculations were 
performed for each component using the first 9 frames before stimulation as a baseline 
estimation. Lastly a low pass filter with a cutoff frequency of 0.05Hz was used to smoothen 
the resulting temporal profiles.  
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Figure 1. Bi-modal optoacoustic and fluorescence imaging of isolated brains. (A) 3D-
rendering of the imaging setup featuring a 512-element spherical matrix transducer array 
inserted into a custom-made 3D-printed holder. The holder features an inlet and outlet to 
facilitate perfusion with ACSF while the excised brain is placed on top of a transparent 
polyethylene foil that is attached to the submerged sample mount. The brain is evenly 
illuminated via seven light guides (fibers) and a sensitive sCMOS camera is positioned at the 
top for concurrent wide-field fluorescence imaging. (B) The distribution of detection elements 
on the spherical array with its effective volumetric imaging field of view indicated by the red 
bounding box. (C) Representative volumetric optoacoustic data recorded from an excised 
GCaMP6f-brain at 488 nm excitation wavelength. (D) The corresponding planar fluorescence 
image. The glass capillary visible on top of the right cortex was used for intracortical 
injections. (E) Maximum intensity projections (axial, sagittal and coronal) of the 3D 
optoacoustic dataset shown in C. (F) Representative coronal, sagittal and transverse 
orthoslices (top to bottom) of the 3D optoacoustic image acquired at 590 nm. Au: auditory 
cortex; Cb: cerebellum; Cc: corpus callosum; D3V: dorsal third ventricle; Hip: hippocampus; 
Hy: hypothalamus; M: medulla; MB: mid brain; M1,M2: primary and secondary motor cortex; 
Ob: olfactory bulbs; P: pons; R/LC: right/left cortex; R/LV: right/left ventricle; S1,S2: primary 
and secondary somatosensory cortex; SSS: superior sagittal sinus; Str: striatum; Th: 
thalamus; V1: primary visual cortex. n=4 independent experiments for panels C-F. 
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Figure 2. Whole-brain volumetric optoacoustic imaging of neuronal activation in the isolated 
brain model. (A) Optoacoustically measured absorption spectrum of purified calcium-
saturated (blue) and calcium-free (red) GCaMP6f-proteins. The dotted line indicates 
maximum difference in optoacoustic signal at 488 nm between the two protein states (n=2 
independent experiments). (B) Time-traces of the normalized optoacoustic data along with 
the moving averages over 50 image frames (solid lines 1,2 and 3) are shown from individual 
voxels whose position is indicated in panel E. Notably, the activation first occurs in the red 
voxel located close to the injection site (see the glass capillary location in Fig. 1D), slowly 
propagating into the rest of the brain (purple and green voxels). Gray traces: Tetrodotoxin 
(TTX) was injected 180s prior to pentylenetetrazol (PTZ), abolishing the activation (n=4 
independent experiments for PTZ injection and n=3 for TTX + PTZ). (C) Optoacoustic 
recordings from a control experiment with an isolated CD-1 mouse brain not expressing 
GCaMP6f proteins. No changes due to PTZ-injection are detected (n=3 independent 
experiments). (D) Results of an additional control experiment where an isolated GCaMP6f-
expressing brain was injected with a phosphate buffered saline, resulting in no optoacoustic 
signal changes (n=3 independent experiments). (E) Temporal evolution of the relative 
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optoacoustic signal changes (∆OA/OA) in two representative slices located at depths of 0.7 
mm and 1.1 mm in a GCaMP6f-expressing brain (the slice locations are indicated in Fig. 1E). 
Injection of the PTZ neurostimulant was done at t=0s. The indicated voxels 1,2 and 3 
correspond to the solid lines in panel B (n=4 independent experiments). (F) Onset activation 
map for the experiment shown in (A), generated for each image voxel by calculating the time 
point (tonset) when the relative optoacoustic signal change (∆OA/OA) exceeded 3 times the 
standard deviation of the background signal (before the PTZ injection). The white color 
represents inactivated voxels (n=4 independent experiments). 
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Figure 3. Non-invasive imaging of the GCaMP6f-brain in vivo. (A) Experimental schematic of 
hind paw electrical stimulation experiment with alternate imaging in either optoacoustic or 
fluorescence mode. (B) Representative planar fluorescence image of a GCaMP6f mouse 
brain. OL: olfactory bulb; LC/RC: left/right cortex; CB: cerebellum; M1,M2: primary and 
secondary motor cortex; S1,S2: primary and secondary somatosensory cortex; Au: auditory 
cortex; V1: primary visual cortex. The approximate bregma- and lambda skull-landmarks (red 
asterisks, B and L) are also indicated (n=3 biologically independent animals). (C) Maximum 
intensity projections of the representative volumetric optoacoustic image recorded non-
invasively from a GCaMP6f-expressing mouse brain at 488 nm. Note the shallow penetration 
depth of 1-2mm at this wavelength (n=3 biologically independent animals). (D) Maximum 
intensity projections of the volumetric optoacoustic images recorded non-invasively at 650nm 
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in vivo, demonstrating the whole-brain recording capacity of the system down to ~7mm 
depth. Bregma- and lambda skull-landmarks are indicated (white asterisks, B and L). Major 
veins are visible and have been labeled accordingly. RRV: rostral rhinal vein; SSS: superior 
sagittal sinus; CS: confluence of sinuses; TS: transverse sinus; LHV: longitudinal 
hippocampal vein. (n=3 biologically independent animals). (E) The GCaMP6f-protein is prone 
to bleaching over the course of the imaging experiment. The normalized average 
fluorescence signal of the whole brain area is plotted (left panel). For optoacoustic (OA) 
signal decay, the averages of each stimulus cycle (blue diamonds) and a linear fit (blue line) 
are plotted (n=3 biologically independent animals). 
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Figure 4. Non-invasive imaging of somatosensory-evoked rapid calcium transients in the 
GCaMP6f-brain in vivo. (A) Temporal sequence of fluorescence-recorded brain activation 
maps (∆F/F) in response to the current stimulus at t=0 at the right hindpaw. Functional 
regions of the brain are indicated as dashed white lines. (B) 4D optoacoustically-recorded 
brain activation maps (∆OA/OA) in response to the stimulus at t=0. Slices across the entire 
brain are shown located at different depths from the brain surface. Functional regions of the 
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brain are indicated as dashed white lines. (C) Schematic of the electrical paw stimulation 
paradigm. One 50 ms long stimulus was repeated every 20 seconds (top panel). Below, 
representative single-voxel optoacoustic and single-pixel fluorescence time traces are 
shown. Note that the volumetric optoacoustic recordings (blue) were carried out at a 25Hz 
rate versus 6.25Hz for planar fluorescence (green). rise is defined as the time required for the 
optoacoustic signal to rise from 20% to 80% of its maximum. (D) Relative optoacoustic signal 
increase versus relative fluorescence signal increase for a set of points in the region 
indicated in red in (A) and for three different time points (160ms, 320ms and 640ms). The 
maximum of all slices is taken for calculating the relative optoacoustic signal increase. The 
dashed line of the best fit was determined using a least square method - its slope and 
coefficient of determination are denoted by m and R2, respectively. (E) Background-
subtracted and normalized (∆F/F) fluorescence signal traces following the stimulus in three 
pixels located in the primary somatosensory cortex on each hemisphere (1 and 2) and inside 
the superior sagittal sinus (3). (F) Background-subtracted and normalized (∆OA/OA) 
optoacoustic signal response traces for single voxels located bilaterally in the primary 
somatosensory cortex outside major vessels (voxels 1 and 2, approx. 1mm depth) and inside 
the superior sagittal sinus (voxel 3). (G) Background-subtracted and normalized (∆OA/OA) 
optoacoustic signal traces following the stimulus in control wild-type mice are shown for 
single voxels at similar locations as in (F). n=4 independent experiments in n=3 biologically 
independent animals for all panels. 
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Figure 5. Comparison of GCaMP6f and GCaMP6s responses to electrical stimulation of the 
right or left hind paw for n=2 independent animal experiments, respectively. (A) Maximum 
intensity projection along the depth direction of the three-dimensional images of GCaMP6f- 
(top) and GCaMP6s-expressing (bottom) mice. P1 and P2 indicate locations for the time 
profiles shown in (C). (B) Relative increase in optoacoustic signal with respect to the 
baseline for a slice at approximately 1 mm depth at different time points following the 
stimulation pulse. The baseline is defined as the average of 250 frames from 10 to 20 
seconds after the stimulations pulse. (C) Fitted time profiles of the relative increase in 
optoacoustic and fluorescence signals corresponding to the P1 and P2 positions in (A) for 
the GCaMP6f (blue) and GCaMP6s (violet) mice. (D) Boxplots of the statistical distribution of 
the estimated signal time-to-peak (tpeak) and decays (tdecay) values within the cortex. Data 
points (10 independent pixels/voxels for each boxplot) are also shown as black circles. The 
maximum, minimum, median, 25th and 75th percentiles for each plot are, respectively, 
tpeak,OA(6f) – 0.3198s, 0.2001s, 0.2806s, 0.2413s, 0.2806s; tpeak,OA(6s) – 0.4202s, 0.1609s, 
0.3002s, 0.2413s, 0.3610s; tdecay,OA(6f) – 0.7083s, 0.2766s, 0.4513s, 0.3021s, 0.6318s; 
tdecay,OA(6s) – 1.2145s, 0.5749s, 0.9153s, 0.7809s, 1.0320s; tpeak,F(6f) – 0.3993s, 0.2205s, 
0.2566s, 0.2395s, 0.3183s; tpeak,F(6s) – 1.0010s, 0.2912s, 0.4295s, 0.3114s, 0.5005s; 
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tdecay,F(6f) – 1.0841s, 0.2830s, 0.7029s, 0.4412s, 1.0118s, tdecay,F(6s) – 2.8850s, 0.8673s, 
1.1777s, 1.0681s, 1.2842s. 
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LINKS TO ORIGINAL FIGURE FILES: 
Figure1: 
https://drive.google.com/file/d/1TM7JXlng4jE4oTmPr8lukcgKAH8gmo8W/view?usp=sharing 
Figure2: 
https://drive.google.com/file/d/1aCOs1xQItDtjbw8sy6pQtUPe3Qpz_9ol/view?usp=sharing 
Figure3: 
https://drive.google.com/file/d/14NjnwT6i58-UsvsVUAn0cYN85MrUhdtE/view?usp=sharing 
Figure4: 
https://drive.google.com/file/d/1fR0UUTi_5-WUzmdWU6Is5Bq-zgbuS3tR/view?usp=sharing 
Figure5: 
https://drive.google.com/file/d/1fKKCfaJ2bdut3i7U0LT45mCc-xhDq2LE/view?usp=sharing 
Suppl. Figure 1: 
https://drive.google.com/file/d/18twgmhPafCY4CMDO0rCb_UA515noiRox/view?usp=sharing 
Suppl. Figure 2: 
https://drive.google.com/file/d/183IIVYQwKcGZKo6h7XSRm3klmqF48Wjn/view?usp=sharing 
Suppl. Figure 3: 
https://drive.google.com/file/d/1h6ssbvKLgnDzQj2fYUbvCx5Z_j4tbCsL/view?usp=sharing 
Suppl. Figure 4: 
https://drive.google.com/file/d/1T1wxMw7mKDS_q33XITb_J-sQ30r8YKyy/view?usp=sharing 
Suppl. Figure5: 
https://drive.google.com/file/d/10TgepufnjcvVAmLr8OLStKLoYCf7VlWz/view?usp=sharing 
Suppl. Figure6: 
https://drive.google.com/file/d/1lfkqIuaUwsuKuJNL9ZwLM5JjXLzwTtJS/view?usp=sharing 
Suppl. Figure 7: 
https://drive.google.com/file/d/1v4_SoAdqRm6-KiABehZtM4svBOiao2j1/view?usp=sharing 
Suppl. Figure 8: 
https://drive.google.com/file/d/1eGtICJnEFvUulugZovlB_EcG27Omzf1I/view?usp=sharing 
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SUPPLEMENTARY FIGURES AND VIDEOS 
 
Supplementary Figure 1. The isolated mouse brain preparation. 
Supplementary Figure 2. Experimental set-ups for validation experiments in the excised 
mouse brain preparation. 
Supplementary Figure 3. Assessment of neuronal activity in the isolated mouse brain 
preparation. 
Supplementary Figure 4. Characterization of the spatio-temporal resolution performance of the 
volumetric optoacoustic (OA) imaging system. 
Supplementary Figure 5. Fluorescence imaging of neuronal activation in the excised mouse 
brain model. 
Supplementary Figure 6. Lay-out of the optoacoustic and epifluorescence imaging setups for 
in vivo experiments. 
Supplementary Figure 7. Non-invasive in vivo fluorescence imaging of neuronal activation in 
GCaMP6f-expressing mouse brains under different stimulation current and experimental 
conditions. 
Supplementary Figure 8. Optoacoustic imaging of hemodynamic responses in the mouse 
brain induced by prolonged (20s) current stimulation pulses. 
Supplementary Movie 1. OA calcium activity map in a single 2D slice located at an 
approximate depth of 1 mm in the mouse brain. 
Supplementary Movie 2. OA calcium activity in a single 2D slice located at an approximate 
depth of 0.5 mm in the mouse brain. 
Supplementary Movie 3. Hemodynamic responses across the entire mouse cortex in response 
to paw stimulation. 
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Supplementary Figure 1. The isolated mouse brain preparation. (A) Photograph of a representative 
blood-free excised mouse brain. (B) The skull was cut on both sides in order to be able to swiftly remove 
the upper skull plate together with the brain, which was immediately placed into oxygenated artificial 
cerebrospinal fluid (ACSF). Skull image from www.digimorph.org was adapted with permission from T.B. 
Rowe. (C) Compound microscopic images of a 50 µm-thick coronal mouse brain slice at the location of 
the tracer injection (~Bregma 0 mm). To demonstrate brain viability and functionality of axonal transport, 
10 kDa dextran coupled to Texas-red was injected into the cortex of the excised brain. Labeled neurons 
were detected more than 1 mm away from the injection site. Approximate locations of some major mouse 
brain anatomical structures are indicated. Cg: cingulate cortex; CC: corpus callosum; LV: lateral ventricle 
(n=3 independent experiments). (D) Compound microscopic images of a 50 µm-thick coronal slice after 
intracortical injection of the same tracer into the cortex of a non-vital control brain. No labeled neurons 
were detected (n=3 independent experiments). (E) Compound microscopic images of a 50 µm-thick 
coronal slice after intracortical injection of Texas-red (without dextran) into the cortex of an excised mouse 
brain. No labeled neurons could be detected. Squares in C-E indicate the probe sites examined, >1mm 
away from the injection sites (n=3 independent experiments).  
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Supplementary Figure 2. Experimental set-ups for validation experiments in the excised mouse brain 
preparation. (A) Intracortical injection of the neuronal tracers. Freshly excised mouse brain is submerged 
into artificial cerebrospinal fluid (ACSF) constantly supplied with a mix of 95% O2 / 5 % CO2 to keep the 
solution oxygenized and to maintain a stable and physiological pH. A wireless robotic stereotactic 
injection system was used for the injection. (B) Electroencephalogram(EEG)-recordings were performed 
in a similar setup. Two custom-made needle electrodes connected to a differential amplifier were inserted 
into the cortex of the isolated mouse brain using a micromanipulator. Pentylenetetrazol (PTZ) was 
injected intracortically in the vicinity of the electrodes. EEG-signals were recorded using an acquisition 
module connected to an amplifier and a laptop computer. 
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Supplementary Figure 3. Evaluation of neuronal activity in the isolated mouse brain preparation. (A) 
Time-course of the Electroencephalogram (EEG) (left panels) shows stable EEG-signals in the brain of 
anesthetized CD-1 mice (In Vivo) before the injection of pentylenetetrazol (PTZ), while EEG-signals 
become increasingly variable shortly after PTZ-injection. The time-frequency representation (right panels) 
shows the frequency-spectrum and amplitude of the EEG-signals, revealing strong high-frequency 
neuronal activity at a rate of up to 20 Hz after PTZ-injection in vivo. Similarly, stable EEG-signals are 
initially measured in excised brains (Isolated) with the PTZ injection leading to both variable EEG-signals 
and strong high-frequency content in the time-frequency spectrum. No effects on the recorded EEG 
signals can be observed in control brains (Control) upon PTZ-injection. (B) Statistical analysis of the 
EEG signal changes, measured as the ratio of the root-mean-square (RMS) of the temporal EEG signal 
profiles before and after PTZ injection. A significant increase in the EEG signal was observed for both the 
In Vivo and the Isolated mouse brains when compared to Control brains. In contrast, the injection of a 
lower amount of PTZ (10 times lower concentration as compared to (A)) did not cause a significant EEG 
signal increase. Black dots - individual experiments, black lines - mean value, grey and red bars - 
standard deviation. P-values were calculated using F-test based on a one-way analysis of variance 
(ANOVA), where p-values < 0.05 were considered statistically significant with n=3 (Isolated low/high 
PTZ, In Vivo) and n=5 (Control) biologically independent samples. 
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Supplementary Figure 4. Characterization of the spatio-temporal resolution performance of the 
volumetric optoacoustic (OA) imaging system. (A) Diagram of the spherical matrix array transducer. The 
red box corresponds to the reconstructed volume, that approximately matches the effective field of view 
of the system. (B) The reconstructed volumetric image (top view) of an agar phantom containing sparsely 
distributed 50 µm diameter absorbing microspheres. (C) Representative one-dimensional profiles through 
a single microsphere. (D) Spatio-temporal resolution characterization in in vivo GCaMP6f experiments. 
The relative increase in the OA signal for a slice at a depth of 0.5 mm is shown. (E) Spatio-temporal 
signal profile along a black line indicated in (D). (F) The corresponding fitted spatial and temporal profiles. 
n=4 independent experiments in (C) and n=3 biologically independent animals for panels D-F. 
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Supplementary Figure 5. Fluorescence imaging of neuronal activation in the excised mouse brain 
model. (A) Fluorescence image of an isolated GCaMP6f-expressing brain. PTZ was injected into the right 
cortex of the brain with the glass capillary used for injection visible in the image (n=4 independent 
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experiments). (B) Fluorescence image of an excised CD-1 brain recorded under the same conditions as 
in A (n=3 independent experiments). (C) Time-traces of the fluorescence signal from regions of interest 
close to the injection side (RC: right cortex, blue) and from the opposite side of the cortex (LC: left cortex, 
red) are plotted. The dots represent raw data whilst the solid line is a moving average over 50 
consecutive frames. A clear increase in neuronal activity, as represented by increased GCaMP6f-
fluorescence, can be observed in both hemispheres in response to PTZ (n=4 independent experiments). 
(D) Control experiment with PTZ-injection into an excised CD-1-brain showing no increase in 
fluorescence signal (n=3 independent experiments). (E) Likewise, injection of phosphate buffered saline 
(PBS) into an excised GCaMP6f-brain resulted in no effect on the fluorescence signal (n=3 independent 
experiments).  
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Supplementary Figure 6. Lay-out of the (A) optoacoustic and (B) epifluorescence imaging setups for in 
vivo experiments. Abbreviations: AM: Anesthesia mask; AU: Anesthesia unit; C: Camera; DAQ: Data 
acquisition; FB: Fiber bundle; FR: Fluorescence response; HP: Heating pad; LB: Laser beam; M: Mouse; 
OPO: Optical parametric oscillator (laser); PMD: Physiological monitoring device; PC: Personal computer; 
T: Trigger; TA: Transducer array; SI: Stimulus isolator; UR: Ultrasound response. 
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Supplementary Figure 7. Non-invasive in vivo fluorescence imaging of neuronal activation in GCaMP6f-
expressing mouse brains under different stimulation current and experimental conditions (n=2 biologically 
independent animals for each experiment). Air: In this case, the animal was breathing normal air instead 
of 100% O2. Analgesia: The animal received analgesic treatment before the stimulation experiment.   
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Supplementary Figure 8. Optoacoustic imaging of hemodynamic responses in the mouse brain induced 
by prolonged (20s) current stimulation pulses. (A) Volumetric optoacoustic image of the unmixed 
oxygenized (HbO) and deoxygenized (HbR) hemoglobin components (n=4 biologically independent 
animals). Three volumes of interest (VOI) were selected to analyze the hemodynamic response in terms 
of the relative optoacoustic signal changes ΔOA/OA0, where OA0 is the mean value before stimulation. 
VOI 1 is contralateral to the stimulated paw. Both VOI 1 and 2 are located in opposing 
somatosensoricortical regions. VOI 3 is located close to the confluence of sinuses and outside of the 
cortex. The corresponding hemodynamic response for each VOI is plotted in (B) for both HbO and HbR 
and also for total hemoglobin (HbT). In contralateral cortical areas, the HbO value increases by up to 30% 
whilst the HbR decreases by 5%. VOI 3, located outside of the cortex shows little to no response. The 
total blood volume also increases in areas of activation as shown by HbT. The data is the mean response 
of four electrical paw stimulation cycles (125s each). In order to extract the hemodynamic response 
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numerous changes were made to the experimental protocol in comparison to those used to elucidate the 
GCaMP response. These changes required a longer stimulation time (20s) with numerous stimuli - one 
hundred 500μs duration pulses were applied at 0.5mA every 200ms for 20s as opposed to a single paw 
stimulus for 50ms at 1mA, a longer cycle length in order to see the response (120s), multiple wavelength 
imaging to unmix for HbO and HbR and was carried out in FoxN1 nude mice as opposed to transgenic 
GCaMP BL6 mice.Notably, the duration of the activation is longer than that seen in GCaMP (approx. 80s 
versus 2s) and has a much higher delta when comparing HbO to GCaMP, 40% versus 6% in vivo.  Each 
arrow corresponds to 1 mm in its respective direction. 
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SUPPLEMENTARY MOVIE CAPTIONS 
  
Supplementary Movie 1. Optoacoustic calcium activity map (∆OA/OA) in a single 2D slice located at an 
approximate depth of 1 mm in the brain in response to the stimulus at t=0. The colormap, scalebar and 
functional brain regions are illustrated in Fig. 4. 
 
LINK TO VIDEO 1: 
https://drive.google.com/file/d/1QdFtN-YP3wl-lsQqKXLtUmjwkHHJvn-9/view?usp=sharing 
  
Supplementary Movie 2. Optoacoustic calcium activity map (∆OA/OA) in a single 2D slice located at an 
approximate depth of 0.5 mm in the brain in response to the stimulus at t=0. The colormap, scalebar and 
functional brain regions are illustrated in Fig. 4. 
 
LINK TO VIDEO 2: 
https://drive.google.com/file/d/1Gocj3AKJFS-Og7DWfzDkqGv4rh0-zW2z/view?usp=sharing 
 
Supplementary Movie 3. Relative optoacoustic signal changes (∆OA/OA) representing total hemoglobin 
(HbO) across the entire mouse cortex in response to paw stimulation, as outlined in the methods. The 
video is based on the data presented in Supplemental Figure 8.  
 
 
LINK TO VIDEO 3: 
https://drive.google.com/file/d/16lQRBwdyvkZVHpSHSqiglf5_VCwiKtvz/view?usp=sharing 
 
